Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in children and it is more prevalent in Hispanic males. The gender differences can be explained by body fat distribution, lifestyle, or sex hormone metabolism. We evaluated anthropometric and metabolic differences by gender in children with and without NAFLD. We included 194 participants (eutrophic, overweight, and individuals with obesity). The presence of NAFLD was determined using ultrasonography, and we evaluated the association between this disease with metabolic and anthropometric variables by gender. The mean age was 10.64±2.54 years. The frequency of NAFLD in boys was 24.51% and in girls was 11.96% (OR=2.39; 95%CI=1.10-5.19; p=0.025). For girls, NAFLD was significantly associated with triglycerides (p=0.012), homeostatic model assessment of insulin resistance (HOMA-IR) (p=0.048), and the visceral adiposity index (VAI) (p=0.024). The variables related to NAFLD in a gender-specific manner were body mass index (BMI) (p=0.001), waist circumference (WC) (p<0.001), HDL cholesterol (p=0.021), alanine aminotransferase (ALT) (p<0.001), and aspartate aminotransferase (AST) (p=0.002). In our study NAFLD is more frequent in boys, only ALT, and no other clinical or metabolic variables, were associated with NAFLD in these patients. HOMA-IR, VAI, triglyceride levels, and ALT were associated with NAFLD only in girls. The ALT cut-off points for the development of NAFLD in our study were 28.5U/L in females and 27.5U/L in males. Our findings showed that NAFLD should be intentionally screened in patients with obesity, particularly in boys.
Background and Objectives: Metabolic-dysfunction-associated steatotic liver disease or MASLD is the main cause of chronic liver diseases in children, and it is estimated to affect 35% of children living with obesity. This study aimed to identify metabolic phenotypes associated with two advanced stages of MASLD (hepatic steatosis and hepatic steatosis plus fibrosis) in Mexican children with obesity. Materials and Methods: This is a cross-sectional analysis derived from a randomized clinical trial conducted in children and adolescents with obesity aged 8 to 16 years. Anthropometric and biochemical data were measured, and targeted metabolomic analyses were carried out using mass spectrometry. Liver steatosis and fibrosis were estimated using transient elastography (Fibroscan® Echosens, Paris, France). Three groups were studied: a non-MASLD group, an MASLD group, and a group for MASLD + fibrosis. A partial least squares discriminant analysis (PLS-DA) was performed to identify the discrimination between the study groups and to visualize the differences between their heatmaps; also, Variable Importance Projection (VIP) plots were graphed. A VIP score of >1.5 was considered to establish the importance of metabolites and biochemical parameters that characterized each group. Logistic regression models were constructed considering VIP scores of >1.5, and the receiver operating characteristic (ROC) curves were estimated to evaluate different combinations of variables. Results: The metabolic MASLD phenotype was associated with increased concentrations of ALT and decreased arginine, glycine, and acylcarnitine (AC) AC5:1, while MASLD + fibrosis, an advanced stage of MASLD, was associated with a phenotype characterized by increased concentrations of ALT, proline, and alanine and a decreased Matsuda Index. Conclusions: The metabolic MASLD phenotype changes as this metabolic dysfunction progresses. Understanding metabolic disturbances in MASLD would allow for early identification and the development of intervention strategies focused on limiting the progression of liver damage in children and adolescents.
1 October 2014 in Revista Médica del Hospital General de México
BackgroundVisceral Adiposity Index (VAI) has been strongly associated with adipocytokine synthesis, proinflammatory activity, insulin resistance, dyslipidemia, hypertension and atherosclerosis. VAI is a model that includes and correlates anthropometric and metabolic markers and has been proposed as a risk factor index associated with cardiovascular risk in adults. Some studies conducted in pediatric population have extrapolated VAI calculation in order to predict these abnormalities; nonetheless, no adjustment has been done for pediatric ranges in any of the variables included in the formula. The aim of this study was to design a new sex-specific VAI model adjusted for pediatric population.Subjects and methodsCross-sectional study, 548 children (290 males and 258 females) aged 3-17 years were included for analysis. Eutrophic, apparently healthy children (n=223) were recruited from 3 public schools located nearby the hospital. Overweight (n=89) and obese subjects (n=236) were patients that regularly attend at the Pediatric Obesity Clinic from “Hospital General de México”. Anthropometric evaluation included weight, height, waist circumference (WC). Body mass index (BMI) was calculated and Tg and HDL measured in a 12hour fasting condition (mMol/L).ResultsA non-lineal quadratic regression model accurately explained the relationship between WC and BMI in pediatric population (coefficient of determination R2=0.938; p<0.001 for males and R2=0.907; p<0.001 for females). Medians of triglycerides and HDL-cholesterol values of 223 healthy children were used to calculate the second formula component (Males: median Tg=0.76mmol/l, median HDL-cholesterol=1.37mmol/l; Females: median Tg=0.91mml/l, median HDL-chloesterol=1.42mmol/l).ConclusionsVAI formula construction seemed to be different in children compared to adults. In the present study we propose a new gender-specific visceral adipose index for pediatric Mexican population living in urban areas that could be further used to predict abnormal cardiometabolic outcomes
1 April 2017 in Revista Médica del Hospital General de México
In recent decades there has been a very significant increase in obesity in most developing countries. In addition to environmental, genetic and hormonal factors, nutritional and maternal environment factors influencing critical periods of foetal development have acquired increasing significance since the thrifty phenotype theory was described by Harles and Barker and epidemiological studies demonstrated that perinatal conditions may modify individuals’ future metabolic responses via genomic reprogramming. Perinatal programming corresponds to a critical and accelerated period of developmental plasticity from preconception through early postnatal life. This characteristic may also have a long-term influence on metabolic health and obesity. Epigenetic modifications favour the survival of the individual in critical periods when nutritional restriction is established, but exerts long-term risks, as metabolic programming tracks into infancy and adulthood and induces fat mass accumulation, particularly if energy consumption is exceeded. Although the mechanisms are not yet fully understood, it is evident that hormonal factors such as insulin and leptin may influence the programming of hypothalamic circuits for energy balance regulation. Nutritional interventions in animal models at critical stages of development have demonstrated that microenvironmental modifications might induce a permanent modulation of the progeny genome expression via epigenetic mechanisms. A transgenerational transmission of obesity has been proposed
The differential contribution of monocyte subsets expressing the C-C chemokine receptor 2 (CCR2) to subclinical atherosclerosis in girls and boys is unclear. In this pilot study, we compared classical, intermediate, and nonclassical monocyte subsets expressing CCR2 in 33 obese children of both sexes aged 8 to 16 divided by carotid intima-media thickness (IMT), considering values above the 75th percentile (p75) as abnormally high IMT. Obesity was defined as body mass index above the 95th percentile according to age and sex. Flow cytometry analyses revealed that boys but not girls with IMT ≥ p75 displayed increased CCR2+ cell percentage and CCR2 expression in the three monocyte subsets, compared to boys with IMT < p75. The CCR2+ cell percentage and CCR2 expression in the three monocyte subsets significantly correlated with increased IMT and insulin resistance in boys but not girls, where the CCR2+ nonclassical monocyte percentage had the strongest associations (r = 0.73 and r = 0.72, respectively). The role of CCR2+ monocyte subpopulations in identifying an abnormally high IMT shows a marked sexual dimorphism, where boys seem to be at higher subclinical atherosclerosis risk than girls.
Background: Metabolomic profiling can uncover metabolic differences among seemingly healthy children, providing opportunities for personalized medicine and early detection of risk biomarkers for future metabolic disorders. This study aimed to identify and internally validate metabotypes in apparently healthy schoolchildren using targeted serum metabolomics and to assess the external validity of this metabotype classification tool in two separate groups of children. Methods: Data from schoolchildren aged 6–11 years were analyzed in two phases. In the first phase, we developed and validated a classification tool using targeted serum metabolomics in healthy children. Metabotypes were identified through unsupervised clustering with a self-organizing map, followed by assessment of cluster stability and classification accuracy. In the second phase, we tested the tool’s consistency by applying it to two additional groups: the same children from phase 1 after a 10-month physical activity intervention, and a separate group diagnosed with metabolic syndrome. Results: Three metabotypes were identified in healthy children: METBA (balanced profile), METLI (high lipid and glucose levels), and METAA (high amino acid levels). Internal validation showed strong cluster stability (ARI = 0.79) and high classification accuracy (0.95). After the intervention, 55% of children were reclassified, indicating diverse metabolic responses to physical activity. Among children with metabolic syndrome, 83% were classified as METLI and 13% as METAA. Conclusions. This tool revealed serum metabolomic diversity, enabling classification of healthy children into three distinct metabotypes. It also detects changes in metabotype classification associated with a physical activity intervention and identifies the majority of children diagnosed with metabolic syndrome within two groups. This supports the potential use of metabotypes as biomarkers and eventually for personalized interventions.